SIGN UP
Back to Resources
Date: April 1, 2020
Category: COVID-19 Response
    Share
    on Social:
Print this
page:

FORE Opinion Letter: Prescribing Buprenorphine During a Public Health Emergency

Legal analysis of four hypothetical scenarios for prescribing buprenorphine for opioid use disorder in the United States during the novel coronavirus outbreak.

View Resource

Related Grants & Resources

Webinar: State Policy Landscape to Address the Opioid and Overdose Crisis in 2024
March 14, 2024
Addiction Policy Forum

COVID-19 Vaccine Navigators for the Substance Use Disorder Population

Mar. 2021 - Aug. 2021
Webinar: Federal Policy and Regulatory Opportunities to Address the Opioid and Overdose Crisis in 2024
January 26, 2024